| 【Company Research】Kintor Pharmaceutical (9939 HK) – Fast clinical progress for Proxalutamide and other core assets |
| 【Company Research】InnoCare Pharma (9969 HK) – Entering into commercial stage |
| 【Company Research】China East Education (667 HK) – YTD number of new students enrolled exceed pre-pandemic level |
| 【Company Research】Haidilao (6862 HK) – Gradual recovery and store expansion intact |
| 【Company Research】Q Technology (1478 HK) – Stronger CCM outlook in 2021; Raise TP to HK$23.0 |
| 【Company Research】Yihai (1579 HK) – Transitions for better long-term growth |
| 【Company Research】Innolight (300308 CH) – Weak 1Q21; Expect demand to pick up in 2Q |
| 【Company Research】Zhongsheng (881 HK) – Foster the pre-owned vehicle sales business |
| 【Fixed Income Research】21Vianet has sufficient cash to repurchase share from Tuspark, but capex need remains (VNET) |
| 【Company Research】Momo (MOMO US) – Wait for more recovery signs |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
